Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners. Our business is fueled by our passion for relentless commitment to the partner network we ...

Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners.

2022年8月8日 · 该品牌是一种 阿片类镇痛药，适用于处治因潜在癌症疼痛已接受并耐受 阿片类药物 治疗的癌症患者的持续爆发性疼痛。 Adalvo将成为该品牌的唯一和独家所有者，并将获得该产品的全部权利，接管包括美国在内的全球全部现有业务与市场授权。 该品牌目前由商业伙伴在几个欧盟国家和中国台湾地区销售。 Adalvo将承担这些合作伙伴的供应责任以维持其 业务连续性。 Adalvo首席执行官Anil Okay评论道：“此次收购为Adalvo的转型之旅铺平了道路。 这是一个真 …

Key milestones of Adalvo • 1st Complex Peptide project launched in Europe • Y-o-Y Growth 134 % • First player to launch key oncology products in LATAM • Adalvo won Most Innovative B2B Pharmaceutical Company • Targeting the first launch of innovative product in EU (Pregabalin ER) • Aiming to be Top 3 B2B firm in 2023

2022年8月3日 · 该品牌是一种阿片类镇痛药，适用于处治因潜在癌症疼痛已接受并耐受阿片类药物治疗的癌症患者的持续爆发性疼痛。 Adalvo将成为该品牌的唯一和独家所有者，并将获得该产品的全部权利，接管包括美国在内的全球全部现有业务与市场授权。 该品牌目前由商业伙伴在几个欧盟国家和中国台湾地区销售。 Adalvo将承担这些合作伙伴的供应责任以维持其业务连续性。 Adalvo首席执行官Anil Okay评论道：“此次收购为Adalvo的转型之旅铺平了道路。 这是一个真 …

Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners.

Adalvo, a part of Alvogen Group, is a leading global B2B pharmaceutical company. Its mission is to make a difference for patients around the world, driven by a smart collaboration network and commitment to deliver the highest quality differentiated products and services to its partners.

Adalvo is a global pharmaceutical company, and one of the leading B2B pharmaceutical companies in Europe, with commercial partnerships in more than 100 countries and for over 140 commercial...

Adalvo is a global pharmaceutical company with a declared purpose to make a difference for patients around the world driven by our smart collaboration network and commitment to deliver highest quality differentiated products and services to our partners.

2020年5月5日 · We are excited to announce the launch of our new brand identity for our B2B business, Adalvo. Why ‘Adalvo’? Our B2B business has seen tremendous growth in recent years and in 2019 alone we signed over 100 licensing contracts with our global partners. The introduction of our new identity is designed to support our dynamic growth.